What dose of vancomycin is given for peritonitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vancomycin Dosing for Peritonitis

For peritonitis, vancomycin should be dosed at 15-20 mg/kg IV every 8-12 hours (not to exceed 2g per dose) in patients with normal renal function, targeting trough concentrations of 15-20 mg/L. 1, 2

Dosing Algorithm

Initial Loading Dose

  • Consider a loading dose of 25-30 mg/kg IV (based on actual body weight) for seriously ill patients with peritonitis to rapidly achieve therapeutic levels 3
  • Infuse over 2 hours with antihistamine premedication to minimize red man syndrome risk 1
  • This loading strategy is critical in peritonitis due to expanded extracellular volume from fluid resuscitation 3

Maintenance Dosing

  • Standard dose: 15-20 mg/kg IV every 8-12 hours (actual body weight, max 2g/dose) 1, 2
  • For patients >1g per dose, extend infusion time to 1.5-2 hours 4
  • Adjust frequency based on renal function, not the individual dose 1

Therapeutic Monitoring

  • Target trough: 15-20 mg/L for serious infections like peritonitis 1, 4
  • Measure trough before 4th or 5th dose at steady state 1, 4
  • Monitor troughs in all patients with serious infections, obesity, renal dysfunction, or fluctuating volumes of distribution 1

Route-Specific Considerations

Intravenous Administration (Preferred)

The evidence strongly supports IV vancomycin for peritonitis when treating systemic infection or healthcare-associated intra-abdominal infections requiring gram-positive coverage 2, 5. The 2017 WSES guidelines specifically recommend vancomycin 25-30 mg/kg loading dose then 15-20 mg/kg/dose every 8 hours for critically ill patients with healthcare-associated IAIs 5.

Intraperitoneal Administration (For PD-Associated Peritonitis)

Critical caveat: Recent research reveals that standard IP vancomycin dosing (15 mg/kg every 96 hours) achieves therapeutic serum levels in only 4-5% of patients 6. The commonly recommended 30 mg/kg IP loading dose results in subtherapeutic levels (<15 mg/L) in 60% of patients after the first dose 7.

If IP administration is necessary:

  • Loading dose: 30 mg/kg IP 7, 8
  • Maintenance: Consider continuous dosing (50 mg/L in each dwell) rather than intermittent dosing 9
  • Monitor both serum AND dialysate levels - serum levels do not reliably predict adequate intraperitoneal concentrations 8
  • 23% of patients have dialysate levels below MIC (4 mg/L) despite therapeutic serum levels 8

Key Clinical Pitfalls

Weight-based dosing is essential - traditional 1g every 12 hours underdoses most patients, particularly those who are obese 10. Each 5 mg/kg increase in initial dose increases day 3 levels by 1.38 mg/L 11.

Residual renal function matters - each 1 mL/min increase in GFR decreases vancomycin levels by 0.29 mg/L 11. Patients with preserved kidney function clear vancomycin faster and may need more frequent dosing.

MIC considerations - if vancomycin MIC is ≥2 mg/L, achieving target AUC/MIC >400 is not possible with conventional dosing; consider alternative agents 4, 10.

Duration

Antimicrobial therapy for complicated intra-abdominal infections should be limited to 4-7 days unless source control is inadequate 2. Adjust based on clinical response and adequacy of source control.

References

Research

Evaluation of intraperitoneal vancomycin in peritoneal dialysis-associated peritonitis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2022

Research

Intraperitoneal vancomycin concentrations during peritoneal dialysis-associated peritonitis: correlation with serum levels.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2012

Research

Predictors of serum vancomycin levels in peritoneal dialysis-associated peritonitis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2023

Related Questions

How do I measure vancomycin trough levels for a patient receiving intraperitoneal vancomycin?
In a CAPD patient with peritonitis receiving exchanges every 4 hours with 1.5% dextrose and an 8‑hour dwell for intraperitoneal cefepime, should cefepime be dosed daily or every 48 hours, and how should intraperitoneal vancomycin be dosed and monitored?
What is the appropriate dosing and administration of vancomycin for an adult on continuous ambulatory or automated peritoneal dialysis?
What are the recommended IV (intravenous) antibiotics for peritoneal dialysis peritonitis?
What treatment options are available for a peritoneal dialysis (PD) patient with peritonitis who is unable to drain PD fluid?
Is nifedipine appropriate for treating uterine contractions in preterm labor, and what is the recommended dosing and monitoring?
What is the recommended management for a smoker with a first-time LDL cholesterol of 171 mg/dL?
Is there any reason to repeat thyroid peroxidase antibody testing after a patient has been diagnosed with Hashimoto's thyroiditis?
What are the possible causes and urgent work‑up for a patient presenting with sharp right lower quadrant pain and burning right upper quadrant pain?
What is an appropriate first-line mood stabilizer for a patient with a history of impulse‑control problems, anger management difficulties, post‑traumatic stress disorder, and personality disorder?
What medication adjustments should be made for a patient with schizoaffective disorder, bipolar type, who has sleep apnea and is experiencing excessive sedation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.